Watch Ticker

Allarity Therapeutics, Inc. Common Stock

Go to Allarity Therapeutics, Inc. Common Stock Website

$1.00

-0.01 (-1.00%)

Live

Previous Close

$1.01

Day Range

$0.9922 - $1.035

Previous Day Range

$0.9804 - $1.02

Market Cap

$15.2 million USD

Day Vol.

268408

Previous Day Vol.

368607

Currency

USD

Primary Exchange

Nasdaq

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Thomas Jensen (Ceo) - Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Allarity Therapeutics signed a non-exclusive licensing agreement with an undisclosed EU-based biotechnology company, providing access to proprietary DRP® algorithms in breast cancer and laboratory services, which validates their drug response prediction technology.

Related tickers: ALLR.

Read Full Article

Allarity Therapeutics - Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer

Allarity Therapeutics announced the appointment of Jeff Ervin as its new Chief Financial Officer, succeeding Alexander Epshinsky. Ervin brings nearly two decades of executive leadership experience in healthcare and biotech sectors, and will support the company's clinical development of stenoparib, a cancer treatment drug.

Related tickers: ALLR, BACK, CING, CINGW.

Read Full Article

Trending Tickers

Please sign in to view